Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.972 |
High Similarity |
NPD1512 |
Approved |
0.958 |
High Similarity |
NPD1511 |
Approved |
0.9396 |
High Similarity |
NPD2801 |
Approved |
0.9329 |
High Similarity |
NPD1934 |
Approved |
0.9272 |
High Similarity |
NPD3882 |
Suspended |
0.9267 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9205 |
High Similarity |
NPD3817 |
Phase 2 |
0.9116 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8981 |
High Similarity |
NPD6166 |
Phase 2 |
0.8981 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8981 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8938 |
High Similarity |
NPD6797 |
Phase 2 |
0.8882 |
High Similarity |
NPD7251 |
Discontinued |
0.8712 |
High Similarity |
NPD7808 |
Phase 3 |
0.8712 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8696 |
High Similarity |
NPD7054 |
Approved |
0.8667 |
High Similarity |
NPD6799 |
Approved |
0.8642 |
High Similarity |
NPD7472 |
Approved |
0.8639 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8639 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8634 |
High Similarity |
NPD3818 |
Discontinued |
0.863 |
High Similarity |
NPD1510 |
Phase 2 |
0.8599 |
High Similarity |
NPD7075 |
Discontinued |
0.8581 |
High Similarity |
NPD1549 |
Phase 2 |
0.8528 |
High Similarity |
NPD7074 |
Phase 3 |
0.8526 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8483 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8462 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8452 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8446 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8418 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8367 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8366 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8365 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8356 |
Intermediate Similarity |
NPD943 |
Approved |
0.8354 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8333 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8247 |
Intermediate Similarity |
NPD5401 |
Approved |
0.821 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8199 |
Intermediate Similarity |
NPD919 |
Approved |
0.8176 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.816 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8144 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8105 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8082 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8054 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.805 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8014 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7987 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7922 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7852 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7811 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7805 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD920 |
Approved |
0.7679 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7673 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7673 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7673 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7635 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7613 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7593 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7582 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7562 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7529 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7483 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7432 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7418 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7368 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7326 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7325 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD411 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2354 |
Approved |
0.725 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7213 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7175 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7171 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7167 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD9268 |
Approved |
0.716 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD37 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7118 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7118 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7114 |
Intermediate Similarity |
NPD17 |
Approved |
0.711 |
Intermediate Similarity |
NPD5710 |
Approved |
0.711 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7095 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD9493 |
Approved |
0.707 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7045 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7037 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7 |
Intermediate Similarity |
NPD8313 |
Approved |
0.6988 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6982 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD6385 |
Approved |
0.6982 |
Remote Similarity |
NPD6386 |
Approved |
0.6979 |
Remote Similarity |
NPD7584 |
Approved |
0.6978
|
Remote Similarity |
NPD8150 |
Discontinued |